speb/financial-data huggingface dataset:
Financial ratios for ECR.MC — annual report dated 2022-12-31
Total revenue: 1062268085.1063831
Gross profit: 322986170.212766
Operating income: 120114893.61702128
Net income: 67009574.46808511
Capital expenditures: 26545744.680851065
Depreciation & amortization: 31878723.40425532
Net tangible assets: 363485106.38297874
Owner earnings: 72342553.19148937
Return on net tangible assets (%): 19.902480712721996
Capex to operating income (%): 22.100294044708967
Buffett classification: The Great
Stock price: 3.202127659574468
P/E ratio: 4.369381304513486
Shares outstanding: 91436199
Book value: 383734042.55319154
P/B ratio: 0.7630034071414709
Market cap (USD): 292790381.9042553
Debt to equity: 0.37544564885919435
Current ratio: 1.3487675122889313
Quick ratio: 0.7432040187277025
Effective tax rate (%): 19.684394824802744
Interest coverage ratio: 29.81462899392659
COGS to revenue (%): 69.59466496817328
R&D to revenue (%): 0.02713984128700933
SG&A to revenue (%): 1.2124799205233283
Free cash flow (dilution-adjusted): 59388297.872340426
Buyback yield (%): 5.224854805998393
Retained earnings: 67009574.46808511
Inventory turnover: 5.156262752925289
Receivables turnover: 10.136660338859167
Capitalized R&D asset: 520513.7814313347
ROCI (R&D-adjusted, %): 21.541255415792506
FCF margin (%): 5.590707158108102
Rule of 40 score: 5.590707158108102
Financial ratios for ECR.MC — annual report dated 2023-12-31
Total revenue: 785793333.3333334
Gross profit: 234545555.55555555
Operating income: 17593333.333333332
Net income: 30650000
Capital expenditures: 15771111.11111111
Depreciation & amortization: 35858888.88888889
Net tangible assets: 381278888.8888889
Owner earnings: 50737777.777777776
Return on net tangible assets (%): 13.307261234849962
Capex to operating income (%): 89.6425413666793
Buffett classification: The Gruesome
Stock price: 2.8666666666666667
P/E ratio: 8.551944659053833
Shares outstanding: 91436199
Book value: 403461111.11111104
P/B ratio: 0.6496712981286922
Market cap (USD): 262117103.8
Debt to equity: 0.36145298321468405
Current ratio: 1.277143623702728
Quick ratio: 0.6412944060293417
Effective tax rate (%): -472.0699245133095
Interest coverage ratio: 2.65359477124183
COGS to revenue (%): 70.15175038955677
R&D to revenue (%): 0.0667407602225069
SG&A to revenue (%): 1.4272907493347133
Free cash flow (dilution-adjusted): 44871111.11111111
Buyback yield (%): 4.719688616943703
Retained earnings: 30650000
Inventory turnover: 4.757695774755941
Receivables turnover: 12.833236553676418
Capitalized R&D asset: 831979.0189125296
ROCI (R&D-adjusted, %): 3.068496450191648
Rosenberg metric: -306.76818368183694
FCF margin (%): 5.710294196664659
Revenue growth (%): -26.02683405906538
Rule of 40 score: -20.31653986240072
Financial ratios for ECR.MC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.8777777777777778
Shares outstanding: 91436199
Market cap (USD): 354569260.56666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.MC — annual report dated 2024-12-31
Total revenue: 670235416.6666667
Gross profit: 207637500
Operating income: -2952083.3333333335
Net income: -12142708.333333334
Capital expenditures: 14122916.666666668
Depreciation & amortization: 32770833.333333336
Net tangible assets: 337823958.3333334
Owner earnings: 6505208.333333332
Buffett classification: The Gruesome
Stock price: 3.6770833333333335
Shares outstanding: 91436199
Book value: 355371875.00000006
P/B ratio: 0.9461033555518426
Market cap (USD): 336218523.40625
Debt to equity: 0.5051486558974313
Current ratio: 1.149499452159988
Quick ratio: 0.6093292003408783
Interest coverage ratio: -0.4224806201550388
COGS to revenue (%): 69.02021366870471
R&D to revenue (%): 0.028441499100129615
SG&A to revenue (%): 1.5976973264990844
Free cash flow (dilution-adjusted): -4212500
Buyback yield (%): 0
Retained earnings: -12142708.333333334
Inventory turnover: 3.849569182226383
Receivables turnover: 11.098909818533086
Capitalized R&D asset: 637141.0756501182
ROCI (R&D-adjusted, %): -0.6112422049195009
Rosenberg metric: -51.30773305084746
FCF margin (%): -0.6285105047045036
Revenue growth (%): -14.705891710288535
Rule of 40 score: -15.33440221499304
Financial ratios for ECR.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 337823958.3333334
Buffett classification: The Gruesome
Stock price: 3.6770833333333335
Shares outstanding: 91436199
Book value: 355371875.00000006
P/B ratio: 0.9461033555518426
Market cap (USD): 336218523.40625
Debt to equity: 0.5051486558974313
Current ratio: 1.149499452159988
Quick ratio: 0.6093292003408783
Buyback yield (%): 0
Retained earnings: -12142708.333333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.MC — quarterly report dated 2025-03-31
Total revenue: 194077173.91304347
Gross profit: 57416304.347826086
Operating income: -8589130.434782607
Net income: -13219565.217391305
Capital expenditures: 0
Depreciation & amortization: 8892391.304347826
Net tangible assets: 357603260.8695652
Owner earnings: -4327173.9130434785
Return on net tangible assets (%): -1.2100487849359414
Buffett classification: The Gruesome
Stock price: 3.1847826086956523
Shares outstanding: 91436199
Market cap (USD): 291204416.3804348
Current ratio: 2.0878340150440096
Quick ratio: 2.0878340150440096
COGS to revenue (%): 70.41573556014808
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ECR.MC — quarterly report dated 2025-06-30
Total revenue: 197088235.29411766
Gross profit: 64887058.823529415
Operating income: -6608235.294117647
Net income: -20125882.352941178
Capital expenditures: 0
Depreciation & amortization: 10062352.94117647
Net tangible assets: 348445882.3529412
Owner earnings: -10063529.411764707
Return on net tangible assets (%): -2.8881183338454113
Buffett classification: The Gruesome
Stock price: 3.494117647058824
Shares outstanding: 91436199
Book value: 366542352.94117653
P/B ratio: 0.8716287052294734
Market cap (USD): 319488836.5058824
Debt to equity: 0.7454752038926564
Current ratio: 1.4971739097374652
Quick ratio: 1.0073909230543066
COGS to revenue (%): 67.07715266378152
Buyback yield (%): 0
Retained earnings: -34434117.64705882
Inventory turnover: 1.1630321158364296
Receivables turnover: 2.1934820750517194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0346212221681916
Revenue growth (%): 1.5514763124195636
Rule of 40 score: 1.5514763124195636
Financial ratios for ECR.MC — quarterly report dated 2025-09-30
Total revenue: 171891764.70588237
Gross profit: 59583529.41176471
Operating income: -9595294.11764706
Net income: -14058823.529411765
Capital expenditures: 0
Depreciation & amortization: 10231764.705882354
Owner earnings: -3827058.823529411
Buffett classification: The Gruesome
Stock price: 3.1764705882352944
Shares outstanding: 91436199
Market cap (USD): 290444396.8235294
COGS to revenue (%): 65.3366003230487
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.784360543202503
Rule of 40 score: -12.784360543202503
Financial ratios for ECR.MC — quarterly report dated 2025-12-31
Total revenue: 130800000
Gross profit: 17176470.588235296
Operating income: -5778823.529411765
Net income: -14548235.294117648
Capital expenditures: 0
Depreciation & amortization: 10540000
Net tangible assets: 312904705.88235295
Owner earnings: -4008235.294117648
Return on net tangible assets (%): -1.2809763543871657
Buffett classification: The Gruesome
Stock price: 4.023529411764706
Shares outstanding: 91436199
Book value: 337937647.0588235
P/B ratio: 1.0886512324932898
Market cap (USD): 367896235.9764706
Debt to equity: 0.7765337845129802
Current ratio: 1.1483313772158292
Quick ratio: 0.6706942424681684
COGS to revenue (%): 86.86814175211369
Buyback yield (%): 0
Retained earnings: -63041176.47058824
Inventory turnover: 0.9455001125828463
Receivables turnover: 2.899692243492775
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0223940088377137
Revenue growth (%): -23.905604073698917
Rule of 40 score: -23.905604073698917
Financial ratios for ECR.MC — annual report dated 2025-12-31
Total revenue: 709840000
Gross profit: 203791764.70588237
Operating income: -31278823.529411767
Net income: -63041176.47058824
Capital expenditures: 12683529.411764706
Depreciation & amortization: 40458823.52941176
Net tangible assets: 312904705.88235295
Owner earnings: -35265882.35294118
Return on net tangible assets (%): -11.270486410070346
Buffett classification: The Gruesome
Stock price: 4.023529411764706
Shares outstanding: 91436199
Book value: 337937647.0588235
P/B ratio: 1.0886512324932898
Market cap (USD): 367896235.9764706
Debt to equity: 0.7765337845129802
Current ratio: 1.1483313772158292
Quick ratio: 0.6706942424681684
Interest coverage ratio: -4.604606858330447
COGS to revenue (%): 71.29046479405467
R&D to revenue (%): 0.033810436154626394
SG&A to revenue (%): 1.5411923813817199
Free cash flow (dilution-adjusted): 45184705.88235294
Buyback yield (%): 0
Retained earnings: -63041176.47058824
Inventory turnover: 4.210999833573184
Receivables turnover: 15.73637264618434
Capitalized R&D asset: 540785.4166666666
ROCI (R&D-adjusted, %): -5.5424341875104375
Rosenberg metric: -20.174349083895763
FCF margin (%): 6.36547755583694
Revenue growth (%): 5.909055586811835
Rule of 40 score: 12.274533142648774
Financial ratios for EMSLIMITED.NS — annual report dated 2024-03-31
Total revenue: 95132605.82803693
Gross profit: 29068329.535915576
Operating income: 23777371.38745653
Net income: 18307135.148099292
Capital expenditures: 2861578.126873726
Operating cash flow: -13900455.69013071
Depreciation & amortization: 783235.399928049
Net tangible assets: 94967825.87840268
Owner earnings: 16228792.421153614
Return on net tangible assets (%): 17.08872691466376
Capex to operating income (%): 12.03488005567898
Buffett classification: The Great
Stock price: 4.809021113243762
P/E ratio: 14.587144364102782
Shares outstanding: 55530807
Book value: 95996786.18539393
P/B ratio: 2.7818517047302613
Market cap (USD): 267048823.2984645
Debt to equity: 0.08826131406045991
Current ratio: 6.343969194452514
Quick ratio: 5.391369601176649
Effective tax rate (%): 26.174516766583185
Interest coverage ratio: 41308.229166666664
COGS to revenue (%): 69.44440942944429
SG&A to revenue (%): 0.49057695924472483
Free cash flow (dilution-adjusted): -17840112.723348122
Buyback yield (%): 0
Retained earnings: 70207123.15625374
Inventory turnover: 6.199731488640034
Receivables turnover: 3.2697828857450455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.61089951192811
FCF margin (%): -18.752889787962044
Revenue growth (%): 45.147472347279475
Rule of 40 score: 26.39458255931743
Financial ratios for EMSLIMITED.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 104951612.51791687
Buffett classification: The Gruesome
Stock price: 9.008719541328238
Shares outstanding: 55530807
Book value: 105981354.51505017
P/B ratio: 4.720278094724539
Market cap (USD): 500261466.16662693
Debt to equity: 0.08855182474808568
Current ratio: 6.250825607314752
Quick ratio: 5.605120705729794
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMSLIMITED.NS — quarterly report dated 2024-12-31
Total revenue: 28591968.760927845
Gross profit: 9795022.729921902
Operating income: 7987422.776547383
Net income: 5897458.911295022
Capital expenditures: 0
Depreciation & amortization: 298962.5830516377
Owner earnings: 6196421.49434666
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.901620235458678
P/E ratio: 23.308554182101545
Shares outstanding: 55530807
Market cap (USD): 549844962.2825503
Effective tax rate (%): 27.50729305769683
Interest coverage ratio: 50.31138032305434
COGS to revenue (%): 65.74204871366808
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMSLIMITED.NS — annual report dated 2025-03-31
Total revenue: 113688555.06195931
Gross profit: 36258078.09212064
Operating income: 29016717.32522796
Net income: 21485094.6925415
Capital expenditures: 715934.0659340658
Operating cash flow: 4236707.972878185
Depreciation & amortization: 1124444.704231938
Net tangible assets: 113326981.52910918
Owner earnings: 21893605.33083937
Return on net tangible assets (%): 19.31896979468722
Capex to operating income (%): 2.467315850754807
Buffett classification: The Great
Stock price: 7.195822149609056
P/E ratio: 18.598466365381313
Shares outstanding: 55530807
Book value: 114368552.72387186
P/B ratio: 3.49387835623857
Market cap (USD): 399589810.99626565
Debt to equity: 0.08789639588162672
Current ratio: 7.554322607694804
Quick ratio: 7.062459055716477
Effective tax rate (%): 26.185684271913445
Interest coverage ratio: 29.426779532413335
COGS to revenue (%): 68.1075389933839
SG&A to revenue (%): 0.6265347814208017
Free cash flow (dilution-adjusted): 3495054.9450549446
Buyback yield (%): 0
Retained earnings: 89250070.14262332
Inventory turnover: 13.571768423123263
Receivables turnover: 2.5809917991454125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.282047462700596
FCF margin (%): 3.074236402380318
Revenue growth (%): 19.505351579945554
Rule of 40 score: 22.579587982325872
Financial ratios for EMSLIMITED.NS — quarterly report dated 2025-03-31
Total revenue: 31545779.75216273
Gross profit: 9232511.10591536
Operating income: 7285749.357025952
Net income: 5485632.452653728
Capital expenditures: 0
Depreciation & amortization: 294236.6144493804
Net tangible assets: 113326981.52910918
Owner earnings: 5779869.067103108
Return on net tangible assets (%): 5.100170311708594
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.195822149609056
P/E ratio: 18.21074481589448
Shares outstanding: 55530807
Book value: 114368552.72387186
P/B ratio: 3.49387835623857
Market cap (USD): 399589810.99626565
Debt to equity: 0.08789639588162672
Current ratio: 7.554322607694804
Quick ratio: 7.062459055716477
Effective tax rate (%): 25.156117160844936
Interest coverage ratio: 33.51922766632604
COGS to revenue (%): 70.73297544568574
Buyback yield (%): 0
Retained earnings: 89250070.14262332
Inventory turnover: 3.9109989590761187
Receivables turnover: 0.7161617877332201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.845842602744724
Revenue growth (%): 10.330911508519112
Rule of 40 score: 10.330911508519112
Financial ratios for EMSLIMITED.NS — quarterly report dated 2025-06-30
Total revenue: 27953299.78937515
Gross profit: 8545693.891879242
Operating income: 6033501.0531242695
Net income: 4453955.06669787
Capital expenditures: 0
Depreciation & amortization: 298303.29978937516
Owner earnings: 4752258.366487246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.269482798970279
P/E ratio: 25.48961689714237
Shares outstanding: 55530807
Market cap (USD): 403680246.29943836
Effective tax rate (%): 25.13487625607509
Interest coverage ratio: 16.900131104555886
COGS to revenue (%): 69.42867584052671
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.388147609637974
Rule of 40 score: -11.388147609637974
Financial ratios for EMSLIMITED.NS — quarterly report dated 2025-09-30
Total revenue: 19444261.555806085
Gross profit: 6236392.333709132
Operating income: 3797598.6471251408
Net income: 3183303.269447576
Capital expenditures: 0
Depreciation & amortization: 279503.94588500564
Net tangible assets: 115717271.70236753
Owner earnings: 3462807.2153325817
Return on net tangible assets (%): 2.992472225096311
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.125140924464486
P/E ratio: 17.882637484975078
Shares outstanding: 55530807
Book value: 117625772.26606537
P/B ratio: 2.891662362520926
Market cap (USD): 340134018.52423894
Debt to equity: 0.15798120000314375
Current ratio: 7.957327968759245
Quick ratio: 6.94697453799578
Effective tax rate (%): 22.740838566019708
Interest coverage ratio: 12.699705926707887
COGS to revenue (%): 67.92682347020305
Buyback yield (%): 0
Inventory turnover: 1.1434558673536614
Receivables turnover: 0.4324905143050874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7712343558786934
Revenue growth (%): -30.440192384025046
Rule of 40 score: -30.440192384025046
Financial ratios for EMSLIMITED.NS — quarterly report dated 2025-12-31
Total revenue: 22318681.073855408
Gross profit: 6009568.898295645
Operating income: 3131747.7999331625
Net income: 2147766.514425755
Capital expenditures: 0
Depreciation & amortization: 293193.7172774869
Owner earnings: 2440960.231703242
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.834020274033642
P/E ratio: 17.578617707225966
Shares outstanding: 55530807
Market cap (USD): 268437046.8714493
Effective tax rate (%): 29.0061860225348
Interest coverage ratio: 8.073081782678612
COGS to revenue (%): 73.07381704855587
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 14.782867993210141
Rule of 40 score: 14.782867993210141
Financial ratios for ENSC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 151
Buffett classification: The Gruesome
Stock price: 16920
Shares outstanding: 15365530
Market cap (USD): 259984767600
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENSC — annual report dated 2022-12-31
Total revenue: 0
Operating income: -24222095
Net income: -24172292
Capital expenditures: 0
Operating cash flow: -17887439
Depreciation & amortization: 0
Net tangible assets: -3714444
Owner earnings: -24172292
Buffett classification: The Gruesome
Stock price: 135
Shares outstanding: 15365530
Book value: -4029652
Market cap (USD): 2074346550
Debt to equity: -1.1003612718914686
Current ratio: 0.5599166755598196
Quick ratio: 0.5599166755598196
Interest coverage ratio: -221.1558548276649
Free cash flow (dilution-adjusted): -18959282
Buyback yield (%): 0
Retained earnings: -110931063
Receivables turnover: 0
Capitalized R&D asset: 19835875
ROCI (R&D-adjusted, %): -67.6531327532695
Rule of 40 score: 0
Financial ratios for ENSC — annual report dated 2023-12-31
Total revenue: 0
Operating income: -10718187
Net income: -10613074
Capital expenditures: 0
Operating cash flow: -10779982
Net tangible assets: -322858
Owner earnings: -10613074
Buffett classification: The Gruesome
Stock price: 15.9
Shares outstanding: 15365530
Book value: -651267
Market cap (USD): 244311927
Debt to equity: -1.3123603683281972
Current ratio: 0.6867364904031367
Quick ratio: 0.6867364904031367
Interest coverage ratio: -30.282069248047012
Free cash flow (dilution-adjusted): -11659142
Buyback yield (%): 0
Retained earnings: -121557074
Receivables turnover: 0
Capitalized R&D asset: 20877509.25
ROCI (R&D-adjusted, %): -60.59375917357698
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 15365530
Market cap (USD): 55315908
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.14
Shares outstanding: 15365530
Market cap (USD): 125075414.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENSC — annual report dated 2024-12-31
Total revenue: 0
Operating income: -6730134
Net income: -7986935
Capital expenditures: 0
Operating cash flow: -7502700
Depreciation & amortization: 0
Net tangible assets: 3708422
Owner earnings: -7986935
Return on net tangible assets (%): -215.37287288232028
Buffett classification: The Gruesome
Stock price: 8.14
Shares outstanding: 15365530
Book value: 3379939
P/B ratio: 37.005228260036645
Market cap (USD): 125075414.2
Debt to equity: 0.08925013143728333
Current ratio: 2.421479369535207
Quick ratio: 2.421479369535207
Interest coverage ratio: -5.215363084333764
Free cash flow (dilution-adjusted): -7613423
Buyback yield (%): 0
Retained earnings: -129544299
Receivables turnover: 0
Capitalized R&D asset: 18848882.66
ROCI (R&D-adjusted, %): -49.724955904171466
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1967512
Net income: -1945573
Capital expenditures: 0
Operating cash flow: -1707412
Depreciation & amortization: 0
Net tangible assets: 3049001
Owner earnings: -1945573
Return on net tangible assets (%): -63.810179137363356
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 15365530
Book value: 2720518
P/B ratio: 14.458921720054784
Market cap (USD): 39335756.800000004
Debt to equity: 0.0946080856660386
Current ratio: 2.498893353077716
Quick ratio: 2.498893353077716
Interest coverage ratio: -510.246887966805
Free cash flow (dilution-adjusted): -1723663
Buyback yield (%): 0
Retained earnings: -131489872
Receivables turnover: 0
Capitalized R&D asset: 1885528
ROCI (R&D-adjusted, %): -15.00125486692006
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1750515
Net income: -1733351
Capital expenditures: 0
Operating cash flow: -2706868
Net tangible assets: 3389061
Owner earnings: -1733351
Return on net tangible assets (%): -51.14546477623153
Buffett classification: The Gruesome
Stock price: 2.23
Shares outstanding: 15365530
Book value: 3060412
P/B ratio: 11.196248054183554
Market cap (USD): 34265131.9
Debt to equity: 0.13871367645924798
Current ratio: 2.1017007493006394
Quick ratio: 2.1017007493006394
Interest coverage ratio: -553.9604430379746
Free cash flow (dilution-adjusted): -2797506
Buyback yield (%): 0
Retained earnings: -133223223
Receivables turnover: 0
Capitalized R&D asset: 3186733.76
ROCI (R&D-adjusted, %): -17.552917558758622
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -3741095
Net income: -3729128
Capital expenditures: 0
Operating cash flow: -1866179
Net tangible assets: 1203363
Owner earnings: -3729128
Return on net tangible assets (%): -309.89219379356024
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 15365530
Book value: 874714
P/B ratio: 41.63224333896565
Market cap (USD): 36416306.1
Debt to equity: 0.4432328738307607
Current ratio: 1.2705562292951622
Quick ratio: 1.2705562292951622
Interest coverage ratio: -587.3912702151044
Free cash flow (dilution-adjusted): -2035680
Buyback yield (%): 0
Retained earnings: -136952351
Receivables turnover: 0
Capitalized R&D asset: 4865831.34
ROCI (R&D-adjusted, %): -52.970399388806975
Rule of 40 score: 0
Financial ratios for ENSC — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2781825
Net income: -2767648
Capital expenditures: 0
Operating cash flow: -1525833
Net tangible assets: 3213720
Owner earnings: -2767648
Return on net tangible assets (%): -86.1197615224724
Buffett classification: The Gruesome
Stock price: 0.92
Shares outstanding: 15365530
Book value: 2884750
P/B ratio: 4.900351018285813
Market cap (USD): 14136287.600000001
Debt to equity: 0.1063204783776757
Current ratio: 1.5855730495394977
Quick ratio: 1.5855730495394977
Interest coverage ratio: -516.8756967670012
Free cash flow (dilution-adjusted): -1550172
Buyback yield (%): 0
Retained earnings: -139719999
Receivables turnover: 0
Capitalized R&D asset: 6227549.930000001
ROCI (R&D-adjusted, %): -21.940147003040977
Rule of 40 score: 0
Financial ratios for ENSC — annual report dated 2025-12-31
Total revenue: 0
Operating income: -10240946
Net income: -10175700
Capital expenditures: 123643
Operating cash flow: -7806292
Depreciation & amortization: 6533
Net tangible assets: 3213720
Owner earnings: -10292810
Return on net tangible assets (%): -320.2771243294376
Buffett classification: The Gruesome
Stock price: 0.92
Shares outstanding: 15365530
Book value: 2884750
P/B ratio: 4.900351018285813
Market cap (USD): 14136287.600000001
Debt to equity: 0.1063204783776757
Current ratio: 1.5855730495394977
Quick ratio: 1.5855730495394977
Interest coverage ratio: -545.6890286140566
Free cash flow (dilution-adjusted): -8107021
Buyback yield (%): 0
Retained earnings: -139719999
Receivables turnover: 0
Capitalized R&D asset: 17717783.88
ROCI (R&D-adjusted, %): -40.08561623909664
Rule of 40 score: 0
Financial ratios for ERH — annual report dated 2021-08-31
Total revenue: 20486499
Net income: 20126077
Capital expenditures: 0
Operating cash flow: 4929657
Net tangible assets: 123609796
Owner earnings: 20126077
Return on net tangible assets (%): 16.281943382545506
Buffett classification: The Gruesome
Stock price: 10.06
P/E ratio: 4.414747079622124
Shares outstanding: 8832161
Book value: 123609796
P/B ratio: 0.7188066199866554
Market cap (USD): 88851539.66000001
Debt to equity: 0.20224934276244577
COGS to revenue (%): 0
SG&A to revenue (%): 1.563122132288196
Free cash flow (dilution-adjusted): 4929657
Buyback yield (%): 0
Retained earnings: 16488788
Receivables turnover: 12.008203197811074
Capitalized R&D asset: 0
FCF margin (%): 24.062954826981418
Rule of 40 score: 24.062954826981418
Financial ratios for ERH — annual report dated 2022-08-31
Total revenue: 5159663
Net income: 4792425
Capital expenditures: 0
Operating cash flow: 3009978
Depreciation & amortization: 107824
Net tangible assets: 120159694
Owner earnings: 4900249
Return on net tangible assets (%): 4.078113747526687
Buffett classification: The Gruesome
Stock price: 9.02
P/E ratio: 16.62333624835026
Shares outstanding: 8832161
Book value: 120159694
P/B ratio: 0.6630017901010966
Market cap (USD): 79666092.22
Debt to equity: 0.2496677463243207
COGS to revenue (%): 0
SG&A to revenue (%): 6.6991390716796815
Free cash flow (dilution-adjusted): 3009978
Buyback yield (%): 0
Retained earnings: 17007990
Receivables turnover: 3.2103428322548533
Capitalized R&D asset: 0
FCF margin (%): 58.33671695225057
Revenue growth (%): -74.8143252783211
Rule of 40 score: -16.477608326070538
Financial ratios for ERH — annual report dated 2023-08-31
Total revenue: -12804803
Net income: -13202880
Capital expenditures: 0
Operating cash flow: 8233249
Depreciation & amortization: 0
Net tangible assets: 98783521
Owner earnings: -13202880
Return on net tangible assets (%): -13.36546811284445
Buffett classification: The Gruesome
Stock price: 7.66
Shares outstanding: 8832161
Book value: 98783521
P/B ratio: 0.684874891835451
Market cap (USD): 67654353.26
Debt to equity: 0.30369437833664586
Free cash flow (dilution-adjusted): 8233249
Buyback yield (%): 0
Retained earnings: 220599
Receivables turnover: -7.932103740256619
Capitalized R&D asset: 0
Revenue growth (%): -348.1713049863916
Rule of 40 score: -348.1713049863916
Financial ratios for ERH — annual report dated 2024-08-31
Total revenue: 19996191
Net income: 19610504
Capital expenditures: 0
Operating cash flow: 9801926
Depreciation & amortization: 0
Net tangible assets: 108666376
Owner earnings: 19610504
Return on net tangible assets (%): 18.046524345304384
Buffett classification: The Gruesome
Stock price: 9.26
P/E ratio: 4.170510398916826
Shares outstanding: 8832161
Book value: 108666376
P/B ratio: 0.7526321744639758
Market cap (USD): 81785810.86
Debt to equity: 0.27607435808846703
COGS to revenue (%): 0
SG&A to revenue (%): 1.770672224525161
Free cash flow (dilution-adjusted): 9801926
Buyback yield (%): 0
Retained earnings: 16376858
Receivables turnover: 14.098057270166706
Capitalized R&D asset: 0
FCF margin (%): 49.01896566201033
Rule of 40 score: 49.01896566201033
Financial ratios for ERH — quarterly report dated 2024-08-31
Capital expenditures: 0
Net tangible assets: 108666376
Buffett classification: The Gruesome
Stock price: 9.26
Shares outstanding: 8832161
Book value: 108666376
P/B ratio: 0.7526321744639758
Market cap (USD): 81785810.86
Debt to equity: 0.27607435808846703
Buyback yield (%): 0
Retained earnings: 16376858
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERH — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 110260663
Buffett classification: The Gruesome
Stock price: 10.07
Shares outstanding: 8832161
Book value: 110260663
P/B ratio: 0.8066327450797207
Market cap (USD): 88939861.27
Debt to equity: 0.2720825286530338
Buyback yield (%): 0
Retained earnings: 19306542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERH — annual report dated 2025-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.21
Shares outstanding: 8832161
Market cap (USD): 99008524.81
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXOZ — annual report dated 2024-12-31
Total revenue: 0
Operating income: -5932105
Net income: -5861335
Capital expenditures: 396451
Operating cash flow: -8505650
Depreciation & amortization: 267382
Net tangible assets: 10420775
Owner earnings: -5990404
Return on net tangible assets (%): -57.48520623466105
Buffett classification: The Gruesome
Stock price: 16.5
Shares outstanding: 9281359
Book value: 10420775
P/B ratio: 14.695876602268065
Market cap (USD): 153142423.5
Debt to equity: 0.13308338391338456
Current ratio: 8.115824173351484
Quick ratio: 8.115824173351484
Free cash flow (dilution-adjusted): -10027740
Buyback yield (%): 0
Retained earnings: -11945958
Receivables turnover: 0
Capitalized R&D asset: 2346482.66
ROCI (R&D-adjusted, %): -35.505236067741016
Rule of 40 score: 0
Financial ratios for EXOZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.5
Shares outstanding: 9281359
Market cap (USD): 153142423.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EXOZ — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1950728
Net income: -1856421
Capital expenditures: 31046
Operating cash flow: -1133533
Depreciation & amortization: 70503
Net tangible assets: 8881631
Owner earnings: -1816964
Return on net tangible assets (%): -20.45754884435077
Buffett classification: The Gruesome
Stock price: 10.45
Shares outstanding: 9281359
Book value: 8881631
P/B ratio: 10.92031424746198
Market cap (USD): 96990201.55
Debt to equity: 0.14934464176681062
Current ratio: 6.521351732904801
Quick ratio: 6.521351732904801
Free cash flow (dilution-adjusted): -1481856
Buyback yield (%): 0
Retained earnings: -13802379
Receivables turnover: 0
Capitalized R&D asset: 575016
ROCI (R&D-adjusted, %): -14.708383197738748
Rule of 40 score: 0
Financial ratios for EXOZ — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -2548045
Net income: -2360286
Capital expenditures: 50573
Operating cash flow: -1537999
Depreciation & amortization: 72256
Net tangible assets: 7235705
Owner earnings: -2338603
Return on net tangible assets (%): -32.32031985825846
Buffett classification: The Gruesome
Stock price: 9.88
Shares outstanding: 9281359
Book value: 7235705
P/B ratio: 12.673240122420692
Market cap (USD): 91699826.92
Debt to equity: 0.19271874682563758
Current ratio: 6.188482122827446
Quick ratio: 6.188482122827446
Free cash flow (dilution-adjusted): -2155826
Buyback yield (%): 0
Retained earnings: -16162665
Receivables turnover: 0
Capitalized R&D asset: 1188251.72
ROCI (R&D-adjusted, %): -22.84763601568753
Rule of 40 score: 0
Financial ratios for EXOZ — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2522208
Net income: -2286991
Capital expenditures: 13310
Operating cash flow: -1856708
Depreciation & amortization: 71603
Net tangible assets: 5374422
Owner earnings: -2228698
Return on net tangible assets (%): -41.46860815916577
Buffett classification: The Gruesome
Stock price: 14.43
Shares outstanding: 9281359
Book value: 5374422
P/B ratio: 24.91989098920777
Market cap (USD): 133930010.37
Debt to equity: 0.24563087900429106
Current ratio: 4.526988069724362
Quick ratio: 4.526988069724362
Free cash flow (dilution-adjusted): -2295726
Buyback yield (%): 0
Retained earnings: -18449656
Receivables turnover: 0
Capitalized R&D asset: 1944521.2500000002
ROCI (R&D-adjusted, %): -25.76041963117054
Rule of 40 score: 0
Financial ratios for EXOZ — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2695490
Net income: -2655036
Capital expenditures: 74988
Operating cash flow: -1973800
Depreciation & amortization: 73599
Net tangible assets: 3397249
Owner earnings: -2656425
Return on net tangible assets (%): -78.19341473056582
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 9281359
Book value: 3397249
P/B ratio: 29.779039776007
Market cap (USD): 101166813.10000001
Debt to equity: 0.36595374669328035
Current ratio: 2.514254570007933
Quick ratio: 2.514254570007933
Free cash flow (dilution-adjusted): -2726654
Buyback yield (%): 0
Retained earnings: -21104692
Receivables turnover: 0
Capitalized R&D asset: 2192443.5700000003
ROCI (R&D-adjusted, %): -39.82466691596056
Rule of 40 score: 0
Financial ratios for EXOZ — annual report dated 2025-12-31
Total revenue: 0
Operating income: -9716471
Net income: -9158734
Capital expenditures: 169917
Operating cash flow: -6502040
Depreciation & amortization: 287961
Net tangible assets: 3397249
Owner earnings: -9040690
Return on net tangible assets (%): -266.11796780277217
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 9281359
Book value: 3397249
P/B ratio: 29.779039776007
Market cap (USD): 101166813.10000001
Debt to equity: 0.36595374669328035
Current ratio: 2.514254570007933
Quick ratio: 2.514254570007933
Free cash flow (dilution-adjusted): -8660062
Buyback yield (%): 0
Retained earnings: -21104692
Receivables turnover: 0
Capitalized R&D asset: 5133132.62
ROCI (R&D-adjusted, %): -84.33743280322827
Rule of 40 score: 0
Financial ratios for FATE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.51
Shares outstanding: 116559186
Market cap (USD): 6819877972.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FATE — annual report dated 2022-12-31
Total revenue: 96300000
Operating income: -308386000
Net income: -281721000
Capital expenditures: 35566000
Operating cash flow: -248208000
Depreciation & amortization: 13758000
Net tangible assets: 483939000
Owner earnings: -303529000
Return on net tangible assets (%): -62.720508163218916
Buffett classification: The Gruesome
Stock price: 10.09
Shares outstanding: 116559186
Book value: 483939000
P/B ratio: 2.43022816251635
Market cap (USD): 1176082186.74
Debt to equity: 0.22593343375921346
Current ratio: 4.402188494620828
Quick ratio: 4.402188494620828
COGS to revenue (%): 0
R&D to revenue (%): 332.76635514018693
SG&A to revenue (%): 87.46832814122534
Free cash flow (dilution-adjusted): -362507000
Buyback yield (%): 0
Retained earnings: -1050804000
Receivables turnover: 2.5025987525987525
Capitalized R&D asset: 320454000
ROCI (R&D-adjusted, %): -10.389664504300608
FCF margin (%): -376.43509865005194
Rule of 40 score: -376.43509865005194
Financial ratios for FATE — annual report dated 2023-12-31
Total revenue: 63533000
Operating income: -190511000
Net income: -160928000
Capital expenditures: 6153000
Operating cash flow: -132263000
Depreciation & amortization: 18282000
Net tangible assets: 368417000
Owner earnings: -148799000
Return on net tangible assets (%): -40.38874427618704
Buffett classification: The Gruesome
Stock price: 3.74
Shares outstanding: 116559186
Book value: 368417000
P/B ratio: 1.1832552668307925
Market cap (USD): 435931355.64000005
Debt to equity: 0.28102937703743314
Current ratio: 8.480585256049523
Quick ratio: 8.480585256049523
COGS to revenue (%): 0
R&D to revenue (%): 271.6635449294068
SG&A to revenue (%): 128.197944375364
Free cash flow (dilution-adjusted): -181875000
Buyback yield (%): 0
Retained earnings: -1211732000
Receivables turnover: 34.79353778751369
Capitalized R&D asset: 387300180
ROCI (R&D-adjusted, %): -21.331935306343162
FCF margin (%): -286.2685533502274
Revenue growth (%): -34.02596053997923
Rule of 40 score: -320.29451389020664
Financial ratios for FATE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.5
Shares outstanding: 116559186
Market cap (USD): 407957151
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FATE — annual report dated 2024-12-31
Total revenue: 13631000
Operating income: -195539000
Net income: -186262000
Capital expenditures: 730000
Operating cash flow: -122874000
Depreciation & amortization: 18962000
Net tangible assets: 318726000
Owner earnings: -168030000
Return on net tangible assets (%): -52.71926356808042
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 116559186
Book value: 318726000
P/B ratio: 0.6034106313887163
Market cap (USD): 192322656.89999998
Debt to equity: 0.2675181817611365
Current ratio: 7.5777218212969215
Quick ratio: 7.5777218212969215
COGS to revenue (%): 0
R&D to revenue (%): 990.396889443181
SG&A to revenue (%): 544.1200205414129
Free cash flow (dilution-adjusted): -165100000
Buyback yield (%): 0
Retained earnings: -1397994000
Receivables turnover: 3.851653009324668
Capitalized R&D asset: 356390140
ROCI (R&D-adjusted, %): -35.578935343824746
FCF margin (%): -1211.2097424987162
Revenue growth (%): -78.54500810602364
Rule of 40 score: -1289.75475060474
Financial ratios for FATE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.65
Shares outstanding: 116559186
Market cap (USD): 192322656.89999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FATE — quarterly report dated 2025-03-31
Total revenue: 1629000
Operating income: -41280000
Net income: -37621000
Capital expenditures: 1196000
Operating cash flow: -33809000
Depreciation & amortization: 3333000
Net tangible assets: 288409000
Owner earnings: -35484000
Return on net tangible assets (%): -12.3033608521232
Buffett classification: The Gruesome
Stock price: 0.79
Shares outstanding: 116559186
Book value: 288409000
P/B ratio: 0.3192749079952429
Market cap (USD): 92081756.94
Debt to equity: 0.28892648981134433
Current ratio: 8.814837174615576
Quick ratio: 8.814837174615576
COGS to revenue (%): 0
R&D to revenue (%): 1788.5819521178637
SG&A to revenue (%): 845.48802946593
Free cash flow (dilution-adjusted): -42386000
Buyback yield (%): 0
Retained earnings: -1435615000
Receivables turnover: 0.6770573566084788
Capitalized R&D asset: 29136000
ROCI (R&D-adjusted, %): -5.468826239156055
FCF margin (%): -2601.9643953345612
Rule of 40 score: -2601.9643953345612
Financial ratios for FATE — quarterly report dated 2025-06-30
Total revenue: 1907000
Operating income: -36968000
Net income: -34070000
Capital expenditures: 1240000
Operating cash flow: -24587000
Depreciation & amortization: 3278000
Net tangible assets: 261364000
Owner earnings: -32032000
Return on net tangible assets (%): -12.255704687715218
Buffett classification: The Gruesome
Stock price: 1.12
Shares outstanding: 116559186
Book value: 261364000
P/B ratio: 0.4994807560337308
Market cap (USD): 130546288.32000001
Debt to equity: 0.31117904531611085
Current ratio: 8.035329403968891
Quick ratio: 8.035329403968891
COGS to revenue (%): 0
R&D to revenue (%): 1438.3848977451494
SG&A to revenue (%): 600.1573151546932
Free cash flow (dilution-adjusted): -33103000
Buyback yield (%): 0
Retained earnings: -1469685000
Receivables turnover: 1.3670250896057348
Capitalized R&D asset: 46951120
ROCI (R&D-adjusted, %): -7.282020105898593
FCF margin (%): -1735.8678552700578
Revenue growth (%): 17.065684468999386
Rule of 40 score: -1718.8021708010585
Financial ratios for FATE — quarterly report dated 2025-09-30
Total revenue: 1741000
Operating income: -34735000
Net income: -32250000
Capital expenditures: 2200000
Operating cash flow: -24374000
Depreciation & amortization: 3227000
Net tangible assets: 234066000
Owner earnings: -31223000
Return on net tangible assets (%): -13.339399998291078
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 116559186
Book value: 234066000
P/B ratio: 0.6274494132424188
Market cap (USD): 146864574.36
Debt to equity: 0.3385583553356746
Current ratio: 7.8706200419764505
Quick ratio: 7.8706200419764505
COGS to revenue (%): 0
R&D to revenue (%): 1484.0896036760482
SG&A to revenue (%): 611.0281447443998
Free cash flow (dilution-adjusted): -31438000
Buyback yield (%): 0
Retained earnings: -1501935000
Receivables turnover: 2.5527859237536656
Capitalized R&D asset: 53830980
ROCI (R&D-adjusted, %): -9.844582561274235
FCF margin (%): -1805.743825387708
Revenue growth (%): -8.704771893025695
Rule of 40 score: -1814.4485972807338
Financial ratios for FATE — quarterly report dated 2025-12-31
Total revenue: 1369000
Operating income: -34721000
Net income: -32374000
Capital expenditures: 955000
Operating cash flow: -23314000
Depreciation & amortization: 3063000
Net tangible assets: 207184000
Owner earnings: -30266000
Return on net tangible assets (%): -14.6082709089505
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 116559186
Book value: 207184000
P/B ratio: 0.5513360215074523
Market cap (USD): 114228002.28
Debt to equity: 0.3757481272685149
Current ratio: 5.78592220897674
Quick ratio: 5.78592220897674
COGS to revenue (%): 0
R&D to revenue (%): 1857.1950328707085
SG&A to revenue (%): 779.035792549306
Free cash flow (dilution-adjusted): -30034000
Buyback yield (%): 0
Retained earnings: -1534309000
Receivables turnover: 1.494541484716157
Capitalized R&D asset: 51788360
ROCI (R&D-adjusted, %): -10.6160278324179
FCF margin (%): -2193.864134404675
Revenue growth (%): -21.367030442274555
Rule of 40 score: -2215.2311648469495
Financial ratios for FATE — annual report dated 2025-12-31
Total revenue: 6646000
Operating income: -147704000
Net income: -136315000
Capital expenditures: 5591000
Operating cash flow: -106084000
Depreciation & amortization: 12901000
Net tangible assets: 207184000
Owner earnings: -129005000
Return on net tangible assets (%): -62.2659085643679
Buffett classification: The Gruesome
Stock price: 0.98
Shares outstanding: 116559186
Book value: 207184000
P/B ratio: 0.5513360215074523
Market cap (USD): 114228002.28
Debt to equity: 0.3757481272685149
Current ratio: 5.78592220897674
Quick ratio: 5.78592220897674
COGS to revenue (%): 0
R&D to revenue (%): 1622.4646403851941
SG&A to revenue (%): 699.9849533554017
Free cash flow (dilution-adjusted): -136961000
Buyback yield (%): 0
Retained earnings: -1534309000
Receivables turnover: 7.255458515283843
Capitalized R&D asset: 255236350
ROCI (R&D-adjusted, %): -33.14431415014882
FCF margin (%): -2060.803490821547
Revenue growth (%): -51.243489105714914
Rule of 40 score: -2112.046979927262
Financial ratios for FINKURVE.NS — quarterly report dated 2025-12-31
Total revenue: 5724273.142475215
Gross profit: 2100534.6997883483
Operating income: 1546875.3481118414
Net income: 777910.2149938733
Capital expenditures: 0
Depreciation & amortization: 65255.65333630389
Owner earnings: 843165.8683301772
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.1072741450373178
P/E ratio: 62.10904229237808
Shares outstanding: 140143988
Market cap (USD): 155177814.49482012
Effective tax rate (%): 29.80620388798424
COGS to revenue (%): 63.304778659110895
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.972313815421259
Rule of 40 score: 5.972313815421259
Financial ratios for FLAIR.NS — annual report dated 2024-03-31
Total revenue: 116206739.4171963
Gross profit: 48665571.41144022
Operating income: 18645017.38817604
Net income: 14265295.598992685
Capital expenditures: 13179577.887036815
Operating cash flow: 9151480.992924811
Depreciation & amortization: 4414210.33697086
Net tangible assets: 107551253.14785945
Owner earnings: 5499928.04892673
Return on net tangible assets (%): 5.113774026756835
Capex to operating income (%): 70.68686294384902
Buffett classification: The Good
Stock price: 2.994961612284069
P/E ratio: 22.127484778125332
Shares outstanding: 105395378
Book value: 107775260.8226406
P/B ratio: 2.92882716138005
Market cap (USD): 315655111.2221689
Debt to equity: 0.07660397986999325
Current ratio: 5.108254197139601
Quick ratio: 3.5012106382888133
Effective tax rate (%): 25.394417609459346
Interest coverage ratio: 18.97958984375
COGS to revenue (%): 58.1215584780114
SG&A to revenue (%): 5.757929431772214
Free cash flow (dilution-adjusted): -4058100.4916656674
Buyback yield (%): 0
Retained earnings: 61188475.83643123
Inventory turnover: 2.4870829513680976
Receivables turnover: 4.509639400289552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.08006149857583
FCF margin (%): -3.49213867630912
Revenue growth (%): 2.302233530510458
Rule of 40 score: -1.189905145798662
Financial ratios for FLAIR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 114224761.10845676
Buffett classification: The Gruesome
Stock price: 3.7221691352126136
Shares outstanding: 105395378
Book value: 114377460.58289537
P/B ratio: 3.4298665225334886
Market cap (USD): 392299422.9856665
Debt to equity: 0.05403354602142657
Current ratio: 5.081572603862707
Quick ratio: 3.244862108915902
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLAIR.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.294789602517776
Shares outstanding: 105395378
Market cap (USD): 347255595.5878307
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLAIR.NS — annual report dated 2025-03-31
Total revenue: 110979003.97474864
Gross profit: 53974117.37198971
Operating income: 13991805.00350713
Net income: 13106464.81178396
Capital expenditures: 15637409.399111526
Operating cash flow: 6482581.248538695
Depreciation & amortization: 5229845.686228665
Net tangible assets: 118859188.68365677
Owner earnings: 2698901.0989010986
Return on net tangible assets (%): 2.270670975286743
Capex to operating income (%): 111.76120161188578
Buffett classification: The Gruesome
Stock price: 2.61430738709301
P/E ratio: 21.02290123444478
Shares outstanding: 105395378
Book value: 118990250.17535654
P/B ratio: 2.315617580976604
Market cap (USD): 275535915.2708601
Debt to equity: 0.0607448538703332
Current ratio: 5.428522431868297
Quick ratio: 3.3157735527993095
Effective tax rate (%): 25.68437533557558
Interest coverage ratio: 31.198263952245654
COGS to revenue (%): 51.36546964841153
SG&A to revenue (%): 6.374073752594504
Free cash flow (dilution-adjusted): -9160229.132569557
Buyback yield (%): 0
Retained earnings: 73629401.44961421
Inventory turnover: 1.6986833648310877
Receivables turnover: 3.666422062001875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.058850270751993
FCF margin (%): -8.254019953768742
Revenue growth (%): -4.498650825817819
Rule of 40 score: -12.75267077958656
Financial ratios for FLAIR.NS — quarterly report dated 2025-03-31
Total revenue: 29994423.661444936
Gross profit: 14016518.587795183
Operating income: 3509165.3027823237
Net income: 3218693.0091185407
Capital expenditures: 0
Depreciation & amortization: 1017021.2765957447
Net tangible assets: 118859188.68365677
Owner earnings: 4235714.285714285
Return on net tangible assets (%): 3.5636405839750607
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.61430738709301
P/E ratio: 21.401226716113364
Shares outstanding: 105395378
Book value: 118990250.17535654
P/B ratio: 2.315617580976604
Market cap (USD): 275535915.2708601
Debt to equity: 0.0607448538703332
Current ratio: 5.428522431868297
Quick ratio: 3.3157735527993095
Effective tax rate (%): 26.527279277356
Interest coverage ratio: 37.95827010622155
COGS to revenue (%): 53.269585220228365
Buyback yield (%): 0
Retained earnings: 73629401.44961421
Inventory turnover: 0.4761241214739207
Receivables turnover: 0.9909281279400837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7735759359897103
Rule of 40 score: 0
Financial ratios for FLAIR.NS — quarterly report dated 2025-06-30
Total revenue: 33763702.316873394
Gross profit: 16873040.01872221
Operating income: 4305476.246197051
Net income: 3387795.4598642644
Capital expenditures: 0
Depreciation & amortization: 1491177.1589047508
Owner earnings: 4878972.618769015
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.1187690147437395
P/E ratio: 49.75469808913695
Shares outstanding: 105395378
Market cap (USD): 328703839.203604
Effective tax rate (%): 25.42327912853312
Interest coverage ratio: 29.471045254305164
COGS to revenue (%): 50.026096485603965
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 12.566598038266418
Rule of 40 score: 12.566598038266418